Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global lung marker market size reached US$ 349.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 665.6 Million by 2027, exhibiting a growth rate (CAGR) of 11.95% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Generally, four major types of lung markers, including EGFR, EML4-ALK, KRAS, and BRAF, are used during lung intervention procedures or lung surgeries and diagnosis. Furthermore, the markers are used to detect, diagnose, predict, and monitor the tumor, based on which the treatment is prescribed to the patient. Lung markers are only used as an additional tool to identify cancer along with several imaging tests and biopsy. Owing to this, lung markers are extensively used in thoracoscopic surgeries across hospitals, ambulatory surgical clinics, and specialty clinics, among several other healthcare facilities.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

The rising demand for lung markers can be attributed to the high prevalence of respiratory disorders, such as pleural effusion, pleural mesothelioma, pleural plaque, etc., due to the increasing air pollution levels, across the globe. Besides this, the high exposure to passive smoking, along with a family history of lung cancer further drives the number of patients suffering from lung cancer, thereby augmenting the demand for lung markers. Additionally, the surging geriatric population, along with the hectic consumer lifestyles leading to a high smoking rate, further accelerate the risks of several respiratory disorders. Apart from this, the increasing healthcare expenditures by various governments for early diagnosis and pre-treatment of life-threatening diseases, such as lung cancer, are also propelling the rising utilization of lung markers at a global level. Furthermore, rising investments in several research and development activities in the field of lung cancer diagnostics and treatment is further catalyzing the demand for lung markers. In addition to this, the increasing usage of lung markers in hospitals, surgery centers, clinics, and their various applications in therapeutic purposes has also catalyzed the product demand.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global lung marker market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on cancer type, marker type and end user.

Breakup by Cancer Type:

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)
     

Breakup by Marker Type:

  • EGFR
  • EML4-ALK
  • KRAS
  • BRAF
  • Others
     

Breakup by End User:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Hospitals
  • Diagnostic Labs
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Others
  • Middle East and Africa
    • Turkey
    • Iran
    • Others
       

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc. etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage  Cancer Type, Marker Type, End-User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Argentina, Colombia, Chile, Peru, Turkey, Iran
Companies Covered Abbott Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Fujirebio Europe N.V., Hologic, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, and BioSpace, Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global lung marker market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global lung marker market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the marker type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global lung marker market and who are the key players?
  • What is the degree of competition in the industry

1 Preface
2 Scope and Methodology 

  2.1 Objectives of the Study
  2.2 Stakeholders
  2.3 Data Sources
    2.3.1 Primary Sources
    2.3.2 Secondary Sources
  2.4 Market Estimation
    2.4.1 Bottom-Up Approach
    2.4.2 Top-Down Approach
  2.5 Forecasting Methodology
3 Executive Summary
4 Introduction

  4.1 Overview
  4.2 Key Industry Trends
5 Global Lung Marker Market
  5.1 Market Overview
  5.2 Market Performance
  5.3 Impact Of COVID-19
  5.4 Market Forecast
6 Market Breakup by Cancer Type
  6.1 Non-Small Cell Lung Cancer (NSCLC)
    6.1.1 Market Trends
    6.1.2 Market Forecast
  6.2 Small Cell Lung Cancer (SCLC)
    6.2.1 Market Trends
    6.2.2 Market Forecast
7 Market Breakup by Marker Type 
  7.1 EGFR
    7.1.1 Market Trends
    7.1.2 Market Forecast
  7.2 EML4-ALK
    7.2.1 Market Trends
    7.2.2 Market Forecast
  7.3 KRAS
    7.3.1 Market Trends
    7.3.2 Market Forecast
  7.4 BRAF
    7.4.1 Market Trends
    7.4.2 Market Forecast
  7.5 Others
    7.5.1 Market Trends
    7.5.2 Market Forecast
8 Market Breakup by End User
  8.1 Hospitals
    8.1.1 Market Trends
    8.1.2 Market Forecast
  8.2 Diagnostic Labs 
    8.2.1 Market Trends
    8.2.2 Market Forecast
  8.3 Others 
    8.3.1 Market Trends
    8.3.2 Market Forecast
9 Market Breakup by Region
  9.1 North America
    9.1.1 United States
      9.1.1.1 Market Trends
      9.1.1.2 Market Forecast
    9.1.2 Canada
      9.1.2.1 Market Trends
      9.1.2.2 Market Forecast
  9.2 Europe
   9.2.1 Germany
      9.2.1.1 Market Trends
      9.2.1.2 Market Forecast
   9.2.2 France
      9.2.2.1 Market Trends
      9.2.2.2 Market Forecast
   9.2.3 United Kingdom
      9.2.3.1 Market Trends
      9.2.3.2 Market Forecast
   9.2.4 Italy
      9.2.4.1 Market Trends
      9.2.4.2 Market Forecast
    9.2.5 Spain
      9.2.5.1 Market Trends
      9.2.5.2 Market Forecast
    9.2.6 Russia
      9.2.6.1 Market Trends
      9.2.6.2 Market Forecast
    9.2.7 Others
      9.2.7.1 Market Trends
      9.2.7.2 Market Forecast
  9.3 Asia Pacific
    9.3.1 China
      9.3.1.1 Market Trends
      9.3.1.2 Market Forecast
    9.3.2 Japan
      9.3.2.1 Market Trends
      9.3.2.2 Market Forecast
    9.3.3 India
      9.3.3.1 Market Trends
      9.3.3.2 Market Forecast
    9.3.4 South Korea
      9.3.4.1 Market Trends
      9.3.4.2 Market Forecast
   9.3.5 Australia
      9.3.5.1 Market Trends
      9.3.5.2 Market Forecast
   9.3.6 Indonesia
      9.3.6.1 Market Trends
      9.3.6.2 Market Forecast
    9.3.7 Others
      9.3.7.1 Market Trends
      9.3.7.2 Market Forecast
  9.4 Latin America
    9.4.1 Brazil
      9.4.1.1 Market Trends
      9.4.1.2 Market Forecast
    9.4.2 Mexico
      9.4.2.1 Market Trends
      9.4.2.2 Market Forecast
    9.4.3 Argentina
      9.4.3.1 Market Trends
      9.4.3.2 Market Forecast
    9.4.4 Colombia
      9.4.4.1 Market Trends
      9.4.4.2 Market Forecast
    9.4.5 Chile
      9.4.5.1 Market Trends
      9.4.5.2 Market Forecast
    9.4.6 Peru
      9.4.6.1 Market Trends
      9.4.6.2 Market Forecast
    9.4.7 Others
      9.4.7.1 Market Trends
      9.4.7.2 Market Forecast
  9.5 Middle East and Africa
    9.5.1 Turkey
      9.5.1.1 Market Trends
      9.5.1.2 Market Forecast
    9.5.2 Iran
      9.5.2.1 Market Trends
      9.5.2.2 Market Forecast
    9.5.3 Others
      9.5.3.1 Market Trends
      9.5.3.2 Market Forecast
10 SWOT Analysis
  10.1 Overview
  10.2 Strengths
  10.3 Weaknesses
  10.4 Opportunities
  10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis

  12.1 Overview
  12.2 Bargaining Power of Buyers
  12.3 Bargaining Power of Suppliers
  12.4 Degree of Competition
  12.5 Threat of New Entrants
  12.6 Threat of Substitutes
13 Price Indicators
14 Competitive Landscape

  14.1 Market Structure
  14.2 Key Players
  14.3 Profiles of Key Players
    14.3.1 Abbott Laboratories
      14.3.1.1 Company Overview
      14.3.1.2 Product Portfolio 
      14.3.1.3 Financials
      14.3.1.4 SWOT Analysis
    14.3.2 Thermo Fisher Scientific Inc
      14.3.2.1 Company Overview
      14.3.2.2 Product Portfolio 
      14.3.2.3 Financials
      14.3.2.4 SWOT Analysis
    14.3.3 Agilent Technologies, Inc.
      14.3.3.1 Company Overview
      14.3.3.2 Product Portfolio 
      14.3.3.3 Financials
      14.3.3.4 SWOT Analysis
    14.3.4 Beckman Coulter, Inc.
      14.3.4.1 Company Overview
      14.3.4.2 Product Portfolio 
      14.3.4.3 Financials
      14.3.4.4 SWOT Analysis
    14.3.5 Fujirebio Europe N.V., Hologic, Inc.
      14.3.5.1 Company Overview
      14.3.5.2 Product Portfolio 
      14.3.5.3 Financials
      14.3.5.4 SWOT Analysis
    14.3.6 F. Hoffmann-La Roche Ltd
      14.3.6.1 Company Overview
      14.3.6.2 Product Portfolio 
      14.3.6.3 Financials
      14.3.6.4 SWOT Analysis
    14.3.7 Siemens Healthineers
      14.3.7.1 Company Overview
      14.3.7.2 Product Portfolio 
      14.3.7.3 Financials
      14.3.7.4 SWOT Analysis
    14.3.8 BioSpace, Inc.
      14.3.8.1 Company Overview
      14.3.8.2 Product Portfolio 
      14.3.8.3 Financials
      14.3.8.4 SWOT Analysis

List of Figures

Figure 1: Global: Lung Marker Market: Major Drivers and Challenges
Figure 2: Global: Lung Marker Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Lung Marker Market: Breakup by Cancer Type (in %), 2021
Figure 4: Global: Lung Marker Market: Breakup by Marker Type (in %), 2021
Figure 5: Global: Lung Marker Market: Breakup by End User (in %), 2021
Figure 6: Global: Lung Marker Market: Breakup by Region (in %), 2021
Figure 7: Global: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 8: Global: Lung Marker (NSCLC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Lung Marker (NSCLC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Lung Marker (SCLC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Lung Marker (SCLC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Lung Marker (EGFR) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Lung Marker (EGFR) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Lung Marker (EML4-ALK) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Lung Marker (EML4-ALK) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Lung Marker (KRAS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Lung Marker (KRAS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Lung Marker (BRAF) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Lung Marker (BRAF) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Lung Marker (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Lung Marker (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Lung Marker (Diagnostic Labs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Lung Marker (Diagnostic Labs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Lung Marker (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Lung Marker (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia Pacific: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia Pacific: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Middle East and Africa: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Middle East and Africa: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Turkey: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Turkey: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Iran: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Iran: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Argentina: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Argentina: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Colombia: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Colombia: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Chile: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Chile: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Peru: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Peru: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Others: Lung Marker Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Others: Lung Marker Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Lung Marker Industry: SWOT Analysis
Figure 91: Global: Lung Marker Industry: Value Chain Analysis
Figure 92: Global: Lung Marker Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Lung Marker Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Lung Marker Market Forecast: Breakup by Cancer Type (in Million US$), 2022-2027
Table 3: Global: Lung Marker Market Forecast: Breakup by Marker Type (in Million US$), 2022-2027
Table 4: Global: Lung Marker Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 5: Global: Lung Marker Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Lung Marker Market: Competitive Structure
Table 7: Global: Lung Marker Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links